CEimpact Podcast
The CEimpact Podcast features two shows:
GameChangers Clinical Updates
Precept2Practice
GameChangers Clinical Update:
Hosted by Rachel Maynard, PharmD, GameChangers helps pharmacists and pharmacy technicians stay current with the developments shaping patient care. Each episode turns emerging evidence and practice updates into insights you can use with confidence.
New episodes arrive every Monday. CEimpact subscribers can listen or watch or use the downloadable Practice Resource to apply what they learn, and claim CE, all included with their CE subscription.
Explore episodes and CE opportunities at ceimpact.com/resources/podcast.
Precept2Practice
Hosted by Kate Newman, PharmD, the Precept2Practice course gives preceptors practical tools to mentor students and residents with confidence.
New episodes arrive on the third Wednesday of each month. Preceptor By Design™ subscribers can earn CE credit and access the Practice Resource for each episode.
Follow the CEimpact Podcast and turn your commute, coffee break, or time between patients into an opportunity to stay current, strengthen your skills, and grow your impact.
CEimpact Podcast
Dupilumab in COPD
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
A new biologic agent, Dupilimab, may be a possible treatment for chronic obstructive pulmonary disorder. Join host, Geoff Wall, as he evaluates the use of dupilimab in COPD with Type 2 inflammation
The GameChanger
Type 2 inflammation is driven by eosinophils and IL-4, 5, and 11. It occurs in 20% of patients with COPD. Dupilimab was able to decrease COPD exacerbations by 50% and improve symptoms
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. PMID: 37272521.
https://www.nejm.org/doi/full/10.1056/NEJMoa2303951
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the different phenotypes of COPD and treatment options
2. Describe the BOREAS trial and the applicability to patients with COPD
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-288-H01-P
Initial release date: 8/21/2023
Expiration date: 8/21/2024
Additional CPE details can be found here.